Signs of methaemoglobinaemia after topical application of EMLA cream in an infant with haemangioma.
Elsner
P
P
Dermatologische Klinik, Universitätsspital Zürich, Schweiz. elsner@derm.unizh.ch
Dummer
R
R
D000772:Anesthesia, Local / Q000009:adverse effects*; D019162:Anesthetics, Combined / Q000009:adverse effects*; D005260:Female; D006391:Hemangioma / Q000151:congenital / Q000601:surgery*; D006801:Humans; D007231:Infant, Newborn; D008012:Lidocaine / Q000009:adverse effects*; D000077442:Lidocaine, Prilocaine Drug Combination; D008708:Methemoglobinemia / Q000139:chemically induced* / Q000175:diagnosis; D011318:Prilocaine / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000151:congenital / Q000601:surgery*
D019162:Anesthetics, Combined; D000077442:Lidocaine, Prilocaine Drug Combination; D011318:Prilocaine; D008012:Lidocaine